Lupin informs about press release

04 Dec 2025 Evaluate
Lupin has informed that it enclosed a Press Release titled ‘Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States.’

The above information is a part of company’s filings submitted to BSE. 

Lupin Share Price

2101.85 9.90 (0.47%)
05-Dec-2025 13:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.00
Dr. Reddys Lab 1280.00
Cipla 1521.40
Zydus Lifesciences 935.15
Lupin 2101.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×